Insider · CIK 0001202098

PAPADOPOULOS STELIOS

Reports to the SEC for 10 companies · ALAMEDA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001202098

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-27	EXELEXELIXIS, INC.A Award	Director	AAward	+8,367 sh	—	—	1,197,595
2026-04-07	OVIDOvid Therapeutics Inc.A Award	Director	AAward	+17.6K sh	$2.56	+$45K	217,578
2026-02-26	OVIDOvid Therapeutics Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+65K sh	—	—	65,000
2025-11-12	EXELEXELIXIS, INC.S Sale	Director	SSale	−100K sh	$43.55	−$4.36M	1,189,228
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−4,000 sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−60K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.U Disposition from Tender	Director	UDisposition from Tender	−976K sh	—	—	64,635
2025-06-25	Regulus Therapeutics Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−64.6K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−9,000 sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−2,325 sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Common Stock Purchase Warrant (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−59.5K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−4,650 sh	—	—	0
2025-05-29	EXELEXELIXIS, INC.A Award	Director	AAward	+9,812 sh	—	—	1,289,228
2025-05-15	EXELEXELIXIS, INC.S Sale	Director	SSale	−15.9K sh	$44.35	−$704K	1,279,416
2025-05-15	EXELEXELIXIS, INC.S Sale	Director	SSale	−20.6K sh	$44.35	−$915K	1,279,416
2025-05-15	EXELEXELIXIS, INC. · Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15.9K sh	—	—	0
2025-05-15	EXELEXELIXIS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15.9K sh	$20.50	+$325K	1,295,290
2025-05-15	EXELEXELIXIS, INC. · Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20.6K sh	—	—	0
2025-05-15	EXELEXELIXIS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+20.6K sh	$19.77	+$408K	1,300,050
2025-04-30	Regulus Therapeutics Inc.A Award	Director	AAward	+62.5K sh	—	—	1,040,888
2025-03-03	OVIDOvid Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+90K sh	—	—	90,000
2024-05-31	EXELEXELIXIS, INC.A Award	Director	AAward	+18.8K sh	—	—	1,279,416
2024-05-20	EXELEXELIXIS, INC.S Sale	Director	SSale	−11.4K sh	$21.00	−$240K	1,260,578
2024-05-20	EXELEXELIXIS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+11.7K sh	$19.57	+$229K	1,272,015
2024-05-20	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+60K sh	—	—	60,000
2024-05-20	EXELEXELIXIS, INC. · Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−11.7K sh	—	—	0
2024-05-16	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-03-14	Regulus Therapeutics Inc.A Award	Director	AAward	+250K sh	$1.60	+$400K	978,388
2023-08-10	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2023-06-13	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2023-06-01	EXELEXELIXIS, INC.A Award	Director	AAward	+20.7K sh	—	—	1,260,329
2023-04-13	Regulus Therapeutics Inc.A Award	Director	AAward	+222K sh	$0.90	+$200K	728,388
2022-06-15	BIIBBIOGEN INC.A Award	Director	AAward	+2,255 sh	—	—	10,095
2022-06-09	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+90K sh	—	—	90,000
2022-05-26	EXELEXELIXIS, INC.A Award	Director	AAward	+19.6K sh	—	—	1,239,611
2022-02-22	EXELEXELIXIS, INC.S Sale	Director	SSale	−84.5K sh	$19.56	−$1.65M	1,220,036
2021-11-30	Regulus Therapeutics Inc.A Award	Director	AAward	+2.22M sh	$0.36	+$800K	5,061,929
2021-07-01	BIIBBIOGEN INC.A Award	Director	AAward	+1,275 sh	—	—	7,840
2021-06-14	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-05-27	EXELEXELIXIS, INC.A Award	Director	AAward	+16.4K sh	—	—	1,304,551
2021-05-11	EXELEXELIXIS, INC.S Sale	Director	SSale	−5,473 sh	$25.01	−$137K	1,288,127
2021-05-11	EXELEXELIXIS, INC. · Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−40K sh	—	—	0
2021-05-11	EXELEXELIXIS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+40K sh	$3.38	+$135K	1,293,600
2021-05-11	EXELEXELIXIS, INC. · Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−40K sh	—	—	0
2021-05-11	EXELEXELIXIS, INC. · Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−40K sh	—	—	0
2021-05-11	EXELEXELIXIS, INC.S Sale	Director	SSale	−10.2K sh	$24.95	−$255K	1,218,675
2021-05-11	EXELEXELIXIS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+40K sh	$3.13	+$125K	1,258,675

Recent filings

Accepted (ET)
May 294
PAPADOPOULOS STELIOS0000939767-26-000083
SEC(opens sec.gov)
Apr 94
PAPADOPOULOS STELIOS0001202098-26-000004
SEC(opens sec.gov)
Mar 24
PAPADOPOULOS STELIOS0001202098-26-000002
SEC(opens sec.gov)
Nov 134
PAPADOPOULOS STELIOS0000939767-25-000137
SEC(opens sec.gov)
Jun 274
PAPADOPOULOS STELIOS0000950170-25-091032
SEC(opens sec.gov)
May 304
PAPADOPOULOS STELIOS0000939767-25-000088
SEC(opens sec.gov)
May 164
PAPADOPOULOS STELIOS0000939767-25-000080
SEC(opens sec.gov)

Companies

Address

C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY

ALAMEDA, CA, 94502